Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19615,139,0.97 [0.50-1.89],0.9310036783954256
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20467,157,0.95 [0.51-1.77],0.8704400650824675
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20254,1173,1.14 [0.91-1.44],0.2635440079330261
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Candidiasis,20478,310,0.76 [0.49-1.19],0.2320885477059517
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19873,2907,0.99 [0.85-1.14],0.8622182820470488
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19866,2947,1.04 [0.90-1.20],0.6075066576080379
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,20297,879,1.10 [0.84-1.44],0.4828667824450631
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,20418,68,0.89 [0.35-2.31],0.8165619629531872
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18582,917,1.14 [0.88-1.48],0.3271311645653312
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17908,1006,1.27 [0.99-1.64],0.059613528353401
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17727,205,0.76 [0.44-1.33],0.3389539851882468
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14407,1910,0.98 [0.82-1.18],0.8659580724515785
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17678,338,1.37 [0.89-2.11],0.1552549597175336
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20470,1052,1.05 [0.82-1.34],0.6839578594315237
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Mycoses,20555,387,0.74 [0.50-1.11],0.1462729990644186
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19819,738,1.33 [0.99-1.77],0.0579567235060759
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20489,1013,1.10 [0.86-1.42],0.4325242862417927
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19577,159,0.90 [0.48-1.69],0.7474740845130865
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20590,42,1.00 [0.30-3.37],0.9964807843842248
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other septicaemia,20357,881,1.13 [0.87-1.48],0.3523779067632578
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20406,56,0.78 [0.27-2.21],0.6378363771796729
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20530,98,1.50 [0.67-3.34],0.3244003694445114
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20515,83,1.81 [0.76-4.35],0.1816795311709242
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19484,403,0.77 [0.52-1.14],0.198279421144034
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,19319,238,1.57 [0.94-2.62],0.0875664256496082
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19487,69,2.46 [0.95-6.37],0.0645870009609845
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20571,59,1.57 [0.57-4.32],0.3811698341232268
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20541,126,0.99 [0.49-2.01],0.983381690954668
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral warts,20462,47,1.01 [0.32-3.20],0.9879631333893776
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20461,46,0.91 [0.29-2.87],0.8674022916942854
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm,20324,302,1.00 [0.63-1.58],0.9970504151706864
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20530,44,0.87 [0.26-2.89],0.8266286834839605
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20496,49,1.45 [0.47-4.54],0.5183624838968811
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20550,109,0.87 [0.41-1.87],0.7292463459438665
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",20265,1417,0.72 [0.58-0.88],0.0018199231481979
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of meninges,20589,26,0.32 [0.07-1.48],0.1467301626737183
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20535,60,1.75 [0.64-4.83],0.2765610964358019
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20576,67,1.02 [0.39-2.68],0.9698013644424486
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20567,395,0.86 [0.58-1.28],0.4585954353078232
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Caecum,20569,296,0.88 [0.55-1.39],0.5759615387529131
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20477,66,0.61 [0.23-1.59],0.3119157401715341
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Descending colon,20564,249,0.60 [0.37-0.99],0.0466760751734683
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Rectum,20527,364,0.84 [0.55-1.27],0.4102734005016712
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20481,643,0.72 [0.53-0.98],0.0364581744457774
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20552,477,0.67 [0.47-0.97],0.0320339857741806
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16029,64,0.60 [0.22-1.60],0.3072899026904714
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16027,62,0.39 [0.15-1.06],0.0659427042303675
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20561,80,0.34 [0.14-0.82],0.0164404051596449
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma, any site",20561,77,0.30 [0.12-0.73],0.0081199169099725
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lung cancer and mesothelioma,13728,308,0.67 [0.43-1.04],0.0751018353132606
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lymphoid leukaemia,16023,58,0.44 [0.16-1.25],0.1228104593429516
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16132,167,1.49 [0.81-2.76],0.2037924660963901
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16208,243,1.01 [0.61-1.67],0.9761085896453868
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16046,81,0.39 [0.16-0.91],0.0304981500628672
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16080,115,1.39 [0.66-2.90],0.3846086871831978
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16092,127,0.63 [0.31-1.26],0.1921281365424105
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16036,71,0.89 [0.35-2.26],0.8055183481011815
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17145,1180,0.95 [0.75-1.19],0.6466779633710602
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16091,126,1.67 [0.82-3.38],0.1551236389937569
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16062,97,0.61 [0.28-1.36],0.2259641524123328
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16073,108,0.99 [0.46-2.12],0.974015798501054
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi,20486,149,0.99 [0.52-1.91],0.9850011974646644
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi of trunk,20562,86,1.17 [0.49-2.76],0.7276156785308365
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanoma in situ,15994,64,1.01 [0.38-2.73],0.9769222678269418
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16054,89,0.43 [0.19-0.99],0.0472067872999519
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16110,145,0.62 [0.32-1.19],0.1510907296058476
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16164,199,0.69 [0.40-1.20],0.1935610155559398
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16055,90,0.71 [0.31-1.64],0.4218303483838187
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Other benign neoplasms of skin,20478,126,1.08 [0.53-2.20],0.8242005296857959
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17001,1036,1.18 [0.92-1.51],0.1926210209035984
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17063,1098,1.20 [0.94-1.52],0.1434286501220532
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,20355,257,0.89 [0.55-1.46],0.6481089550306751
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,19128,69,2.45 [0.95-6.36],0.0650186851839297
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,20156,58,1.27 [0.45-3.62],0.6510097279882845
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20139,2343,0.98 [0.83-1.15],0.7859982796900145
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19533,54,0.42 [0.15-1.23],0.1130774325956438
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,20227,43,0.79 [0.24-2.61],0.7001177510020722
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20293,1234,1.11 [0.89-1.39],0.3692370240287491
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20291,1232,1.10 [0.88-1.38],0.3981788919689283
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,19139,80,1.65 [0.68-3.99],0.2686166674858651
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,20400,921,1.19 [0.92-1.55],0.1845923665935689
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,20279,95,1.08 [0.48-2.45],0.8492806200842455
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,20161,63,0.79 [0.29-2.16],0.6523712981586027
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,20154,56,0.91 [0.31-2.61],0.8564164290324255
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20446,262,0.90 [0.56-1.47],0.6802577114751177
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20507,40,0.75 [0.21-2.62],0.6521703324195299
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",20397,213,0.87 [0.51-1.49],0.6068807756996507
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19541,62,1.45 [0.54-3.93],0.4605774225399931
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15246,310,1.01 [0.64-1.59],0.9630786743275832
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18817,136,0.43 [0.22-0.84],0.0135380741730556
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18847,166,0.39 [0.24-0.63],0.0001332954333207
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14988,52,2.15 [0.70-6.58],0.1795839630800333
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,19431,52,0.57 [0.19-1.69],0.3102197592220017
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18768,186,0.76 [0.42-1.35],0.341092152741465
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",20192,491,0.96 [0.68-1.38],0.8401071712216683
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19903,202,1.29 [0.73-2.26],0.3775226854817448
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19820,119,0.63 [0.31-1.31],0.2165432309346089
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,20335,956,1.25 [0.97-1.62],0.0829487994781553
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17655,923,1.15 [0.88-1.49],0.3068194701228321
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15001,65,1.31 [0.48-3.56],0.5930611465781183
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19864,36,4.08 [1.10-15.18],0.0359846907819681
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15162,226,0.69 [0.41-1.18],0.1751910536251824
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14998,62,1.23 [0.44-3.46],0.6927270400484464
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18249,3313,0.77 [0.67-0.89],0.0002934931504277
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15092,156,0.33 [0.18-0.63],0.0006683790443237
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15409,473,0.69 [0.48-1.00],0.0500143620077687
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20541,231,2.34 [1.39-3.94],0.0014476239606042
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,20384,74,13.14 [5.34-32.37],2.1334650240103456e-08
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15066,130,0.81 [0.40-1.63],0.5502664419742633
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14991,55,0.85 [0.29-2.48],0.7620399255152447
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20437,609,1.51 [1.09-2.08],0.012401684439712
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15193,257,1.45 [0.88-2.38],0.1457235814596643
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15230,294,2.06 [1.30-3.29],0.0022983090592373
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15557,621,0.77 [0.56-1.05],0.1003084414940418
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15052,116,2.17 [1.03-4.56],0.0405459207243472
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,20378,68,15.05 [5.90-38.38],1.389892262199536e-08
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15435,499,0.69 [0.48-0.98],0.0396818693617179
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15282,346,0.57 [0.37-0.88],0.0105156808685038
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18631,49,1.82 [0.59-5.64],0.2993530929900558
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19399,4463,0.81 [0.72-0.91],0.0006004522051296
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19840,12,6.03 [0.63-58.00],0.1196765250246239
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19849,21,1.35 [0.24-7.70],0.7349944883604188
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20446,1525,0.97 [0.79-1.19],0.7901032935003148
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20443,1521,0.97 [0.79-1.19],0.7452916237730772
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19842,14,6.73 [0.89-50.74],0.064199636075979
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,20360,696,0.78 [0.58-1.05],0.099812308109766
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16314,1378,0.93 [0.75-1.15],0.4864282669163338
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20581,206,3.16 [1.85-5.41],2.5587448428564468e-05
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19789,88,1.25 [0.54-2.89],0.6001378052112143
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19727,63,0.48 [0.18-1.29],0.147019865586618
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19738,74,1.27 [0.51-3.17],0.6081572848673518
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14996,60,1.61 [0.57-4.59],0.369001639516389
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,18185,143,3.04 [1.59-5.83],0.0007978495923348
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2174,105,2.22 [1.04-4.75],0.0386919155009307
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2315,273,0.99 [0.62-1.59],0.9759185710201866
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,18123,81,0.98 [0.41-2.37],0.967820763058597
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2130,61,26.50 [10.19-68.90],1.7949226240662415e-11
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19935,1893,0.83 [0.69-0.99],0.0391054535824018
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19979,278,0.94 [0.59-1.51],0.7960769521772001
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18784,202,0.81 [0.47-1.39],0.4392656701849645
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15593,657,1.05 [0.77-1.43],0.775279429163301
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20479,209,2.50 [1.45-4.32],0.0010327502581004
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19562,237,1.22 [0.73-2.04],0.4446743822010324
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Angina pectoris,18114,1270,0.76 [0.61-0.95],0.0169481072970233
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19660,335,1.01 [0.66-1.55],0.9657143560240822
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,19393,68,0.95 [0.37-2.46],0.9199472586033411
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19518,193,1.31 [0.74-2.30],0.3532896847053085
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12054,1959,0.73 [0.61-0.88],0.0007998983172928
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,AV-block,16613,516,0.70 [0.50-1.00],0.0474145949200504
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20531,445,1.20 [0.83-1.75],0.330488098547484
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiac arrest,10309,214,0.65 [0.37-1.15],0.1380582544237711
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16272,175,1.02 [0.56-1.87],0.9383482443125718
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16191,94,0.71 [0.31-1.60],0.4022594150377702
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20590,47,0.62 [0.33-1.17],0.141674463993029
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Conduction disorders,17253,1156,0.76 [0.60-0.96],0.019485416953619
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19083,2260,0.87 [0.73-1.02],0.0924509449353342
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17427,6751,0.78 [0.71-0.86],1.1348939175675557e-06
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19527,230,2.37 [1.40-3.99],0.0012394190286352
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Endocarditis,16168,71,0.46 [0.18-1.18],0.1048596722025494
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Heart failure, strict",20320,1137,0.98 [0.78-1.24],0.8818570739905536
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertension,18452,5870,0.78 [0.70-0.86],2.672292774334242e-06
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18457,5875,0.79 [0.71-0.88],1.042596087137214e-05
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20389,99,0.60 [0.27-1.30],0.1934407097610498
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12753,171,0.55 [0.30-1.00],0.0494509754513231
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12686,104,14.83 [6.95-31.64],3.0865069084051096e-12
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypotension,20464,1021,1.18 [0.92-1.51],0.1949403429613988
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19690,99,0.76 [0.35-1.68],0.5032275272071574
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19202,2358,0.84 [0.72-0.99],0.0370154821912234
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",20236,557,1.05 [0.75-1.46],0.7845530668605952
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16447,350,0.94 [0.61-1.44],0.7708205956156459
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19992,917,0.95 [0.74-1.24],0.7211958918371921
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17637,793,1.08 [0.81-1.43],0.592371021436567
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20453,196,1.46 [0.83-2.57],0.1834112974405632
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20545,323,1.13 [0.73-1.75],0.5909110918639728
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Oesophageal varices,19353,56,0.65 [0.23-1.85],0.4199929956521097
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other aneurysm,19405,80,1.41 [0.59-3.39],0.4445658544937132
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arrhythmias,16513,416,0.91 [0.61-1.34],0.6212693473717499
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,19437,112,1.16 [0.55-2.43],0.6969264360285005
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19562,237,0.91 [0.54-1.51],0.7041845104013832
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16259,162,0.75 [0.40-1.40],0.3671431671663824
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other disorders of veins,19375,78,2.20 [0.90-5.38],0.0826348182896281
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,19340,43,1.22 [0.37-4.06],0.7434905164055032
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,19264,78,0.82 [0.34-1.98],0.6533560983486171
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,19386,89,1.29 [0.56-2.98],0.555172149137571
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17155,1058,0.74 [0.58-0.95],0.0163572575356687
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19499,56,1.11 [0.39-3.18],0.842043046329277
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19796,471,1.33 [0.93-1.91],0.1205163702477673
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,20038,321,0.52 [0.34-0.80],0.0027276222568005
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19740,554,0.92 [0.66-1.29],0.6423915863079261
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10410,315,0.72 [0.45-1.13],0.1527007563024773
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19712,430,1.19 [0.81-1.73],0.3786472171888837
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19593,296,1.81 [1.14-2.87],0.0121387859568312
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Pulmonary embolism,20135,418,1.11 [0.76-1.64],0.589662138180728
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20535,599,0.90 [0.65-1.24],0.5088524370114877
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16504,407,0.70 [0.47-1.04],0.0763939086863951
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Secondary right heart disease,20037,320,0.51 [0.33-0.78],0.0019906811764836
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,19374,188,0.70 [0.39-1.23],0.2159854971610027
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",20223,632,0.98 [0.72-1.34],0.8962119214984521
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",20212,657,0.92 [0.68-1.26],0.6135879752931899
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19673,39,0.40 [0.11-1.39],0.1481923448572082
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,19421,97,1.30 [0.58-2.92],0.522696158851607
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19881,202,1.13 [0.65-1.98],0.6569865611299478
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,19342,267,0.72 [0.44-1.16],0.1735777844078543
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Varicose veins,19624,327,1.37 [0.89-2.13],0.155036300015232
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,19341,62,1.73 [0.63-4.78],0.2885376922410981
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Venous thromboembolism,20376,654,1.28 [0.94-1.75],0.1153785779945266
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20411,427,0.35 [0.25-0.50],1.960634031707669e-09
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17744,838,0.88 [0.67-1.16],0.3786104177009216
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Any mental disorder,19992,3086,0.89 [0.77-1.02],0.0976097934149097
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20356,496,0.32 [0.22-0.45],1.1637088082128876e-10
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17894,988,1.15 [0.89-1.48],0.2951325070526732
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16971,65,1.26 [0.47-3.35],0.6455015086787992
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Smoking dependency,20020,1324,1.01 [0.81-1.26],0.9380533358704024
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18509,1603,0.78 [0.64-0.96],0.0165475143246234
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Vascular dementia,20196,124,1.17 [0.58-2.37],0.664971469400097
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Alzheimer disease,20590,253,1.52 [0.93-2.50],0.0961959907902097
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13779,49,0.89 [0.28-2.80],0.8379966276110411
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Bell's palsy,19402,70,0.93 [0.36-2.40],0.8807140548811059
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19630,298,0.94 [0.59-1.49],0.7955868081506151
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral cysts,20246,197,0.89 [0.50-1.55],0.6706942901911941
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20514,294,0.92 [0.58-1.45],0.7055404393712226
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,20172,54,0.59 [0.20-1.72],0.3354217781543444
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20573,69,1.10 [0.42-2.83],0.8498360155578141
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",20123,74,0.72 [0.29-1.79],0.4740268668507449
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Epilepsy,19213,240,1.00 [0.60-1.67],0.9948344153952312
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,20132,1159,0.98 [0.77-1.23],0.8500255436195603
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20558,410,0.75 [0.51-1.11],0.1455929472189943
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Falls/tendency to fall,20112,1823,0.88 [0.73-1.05],0.1631394891520079
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Generalized epilepsy,20262,52,2.02 [0.68-6.07],0.2082341289291946
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hemiplegia,20448,228,0.88 [0.52-1.49],0.6408048241882887
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hydrocephalus,20099,50,0.69 [0.23-2.11],0.5142369347838687
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20574,53,1.32 [0.45-3.91],0.6137074775113033
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,19352,20,1.21 [0.20-7.21],0.836505292126132
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,19413,81,0.76 [0.31-1.83],0.5395879407549756
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Memory loss,20058,106,1.28 [0.59-2.78],0.5266676728252333
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Migraine,19138,165,0.84 [0.45-1.57],0.588604898964623
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20571,151,0.80 [0.42-1.53],0.4949592813632802
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Motor neuron disease,13887,144,0.85 [0.44-1.66],0.6373270515516998
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20488,59,0.62 [0.34-1.16],0.1354037529949736
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",20173,841,0.97 [0.74-1.28],0.8283876254868572
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Neurological diseases,19441,3043,0.91 [0.79-1.05],0.2154146865655117
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,20307,189,0.98 [0.55-1.73],0.9324107587831044
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19653,321,1.02 [0.66-1.60],0.9204552281339472
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20509,300,1.34 [0.85-2.12],0.2022051017604603
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16254,522,0.91 [0.64-1.29],0.5915837029822597
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,20113,64,1.96 [0.73-5.31],0.1836041251051489
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other disorders of nervous system,20179,130,1.30 [0.65-2.59],0.4620872521040805
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,20261,113,0.58 [0.28-1.21],0.1462170053545888
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other facial nerve disorders,19419,87,1.12 [0.48-2.62],0.7914422152041702
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other headache syndromes,19007,34,0.67 [0.33-1.34],0.2527401015068248
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other neurological diseases,20489,440,0.88 [0.60-1.28],0.493964154045074
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other sleep disorders,19573,600,1.05 [0.76-1.45],0.7867394683465702
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Parkinson's disease,20570,278,0.77 [0.48-1.24],0.2832632852134101
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,20072,23,0.82 [0.16-4.33],0.816405055424178
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Restless leg syndrome,20589,37,1.11 [0.30-4.05],0.8732511029505916
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Sleep apnoea,20335,543,1.08 [0.77-1.51],0.6726119421056278
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Small fibre neuropathy,20259,50,0.74 [0.24-2.30],0.6080632488024758
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20572,165,0.94 [0.51-1.74],0.8376567929314667
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,19361,29,1.03 [0.24-4.45],0.9678973634443157
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20590,256,1.50 [0.92-2.46],0.1062219762811579
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),20168,120,1.19 [0.58-2.44],0.6400853801386248
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,20130,72,0.52 [0.21-1.33],0.1728196289026347
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,20294,248,0.61 [0.37-1.00],0.0490447866004551
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,20435,255,1.41 [0.87-2.31],0.1659372865212262
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19832,40,0.53 [0.15-1.81],0.3079517879734116
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19847,55,1.17 [0.40-3.39],0.772170501148838
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20511,35,0.39 [0.11-1.45],0.1611915592041279
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,20398,103,0.62 [0.29-1.35],0.2306475007749082
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2130,61,27.69 [10.63-72.10],1.0433400039907942e-11
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2596,110,1.95 [0.96-3.97],0.0640909471518135
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,20141,83,1.56 [0.65-3.73],0.3161981909043924
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,20398,852,0.96 [0.73-1.26],0.7668411271996756
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",20323,531,0.89 [0.63-1.24],0.4821068762378564
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19909,117,0.93 [0.45-1.92],0.8497214055082452
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20527,481,0.65 [0.45-0.93],0.0182874480576286
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20588,56,0.71 [0.25-2.05],0.5314607500273318
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20472,426,0.57 [0.39-0.83],0.0036752094322565
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20557,262,0.58 [0.36-0.93],0.0254721134304919
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20513,128,0.71 [0.35-1.43],0.3405920346219914
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19860,68,0.98 [0.38-2.54],0.9654028242437868
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19867,75,0.96 [0.39-2.37],0.9274871760307408
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19827,35,0.83 [0.22-3.09],0.7832620117975971
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20509,586,1.03 [0.74-1.42],0.8716567196991956
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,20091,168,1.30 [0.71-2.39],0.3937296601789221
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,20070,24,1.09 [0.22-5.42],0.9136468523134852
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,20376,81,0.71 [0.30-1.70],0.4476725809801746
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20481,186,0.58 [0.32-1.02],0.0585821412690878
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,20196,150,0.62 [0.32-1.17],0.1398527289231692
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,20455,70,0.60 [0.23-1.54],0.2899269556571295
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,20308,385,1.00 [0.67-1.50],0.985675758549803
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,20159,101,1.08 [0.49-2.36],0.8555105703628147
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,19438,1518,0.78 [0.64-0.96],0.0168675994955853
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20456,161,0.52 [0.28-0.97],0.0395526813292532
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20575,120,1.60 [0.78-3.28],0.2004773054655596
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,20161,369,0.90 [0.60-1.35],0.6095985206497809
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,20352,57,1.42 [0.50-4.03],0.5047749460408851
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20578,46,0.51 [0.16-1.63],0.2575940084445486
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19853,61,1.05 [0.39-2.87],0.9196789527250704
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19921,129,1.03 [0.52-2.07],0.9247383133645676
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19650,104,0.78 [0.36-1.67],0.5165791307559531
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,20086,40,0.77 [0.22-2.69],0.6802607225576478
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19602,56,0.81 [0.28-2.32],0.6938244620696297
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19966,43,0.33 [0.10-1.09],0.0681102240563354
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",20094,171,0.65 [0.36-1.19],0.1615392724607225
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19889,97,0.93 [0.42-2.05],0.8512577508204154
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19652,106,0.62 [0.29-1.34],0.2227874129182704
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19622,76,0.78 [0.31-1.91],0.5811916677314914
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19150,1230,0.76 [0.61-0.96],0.0183150020794804
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19840,48,0.46 [0.15-1.41],0.1742809189353859
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,20383,325,1.08 [0.69-1.67],0.7447121243080332
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,20118,60,0.87 [0.32-2.37],0.7857873598914037
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),20188,130,1.22 [0.61-2.44],0.5658185668265209
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,20431,53,0.69 [0.23-2.05],0.5069227372650882
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20554,108,1.51 [0.71-3.22],0.289464292720272
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20474,98,1.48 [0.67-3.27],0.3358407662343021
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,20423,45,1.94 [0.59-6.32],0.2739773515662134
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,20424,46,0.60 [0.19-1.91],0.3873942378322683
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20503,804,1.06 [0.81-1.41],0.6584165362234693
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,20295,596,1.18 [0.85-1.63],0.3215598558248802
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19811,112,1.43 [0.68-3.01],0.3501267370647737
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19770,71,0.46 [0.18-1.16],0.1007161667209745
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute pharyngitis,20402,49,1.55 [0.50-4.80],0.4431424911937462
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20515,162,1.31 [0.71-2.44],0.3913614908977809
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20406,53,1.79 [0.61-5.24],0.2869480416967814
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza,18657,87,0.57 [0.24-1.33],0.1945449366552135
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18654,84,0.53 [0.22-1.24],0.1433282259624944
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13510,90,0.43 [0.19-1.01],0.0524900677277622
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic rhinitis,20500,238,1.07 [0.63-1.79],0.8096240983673288
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14363,1241,0.49 [0.39-0.61],5.985925699885357e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14636,1216,0.49 [0.39-0.61],9.827411552728742e-10
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),20251,126,1.20 [0.59-2.42],0.6143854188061151
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18646,76,1.10 [0.44-2.73],0.8347445908880626
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bronchiectasis,17886,252,0.40 [0.24-0.66],0.0002996275782622
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17670,36,0.77 [0.21-2.85],0.6923132878832422
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19849,2215,0.63 [0.53-0.75],8.46040093181406e-08
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19321,67,0.73 [0.28-1.94],0.5343794517130216
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic sinusitis,19389,135,0.60 [0.30-1.19],0.1437370991283749
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",20398,1127,0.56 [0.44-0.70],8.780206323732608e-07
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Deviated nasal septum,19380,126,0.73 [0.36-1.48],0.3811508313031235
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18838,4522,0.80 [0.71-0.90],0.000251529157445
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19602,348,0.67 [0.44-1.03],0.0665478437363481
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Early onset COPD,19552,281,0.65 [0.40-1.04],0.0703173914509668
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Emphysema,17949,315,0.71 [0.46-1.11],0.1350778184535821
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19771,309,0.49 [0.31-0.76],0.00151664961658
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20374,1804,0.83 [0.69-1.00],0.0490157971099475
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Interstitial lung disease,19793,331,0.54 [0.35-0.84],0.0053718985227879
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Later onset COPD,19625,846,0.50 [0.38-0.66],5.763991378903946e-07
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20573,339,0.80 [0.52-1.22],0.2986232346551848
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Nasal polyp,19387,133,0.65 [0.33-1.29],0.2188685245306543
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,20351,838,1.10 [0.84-1.45],0.4849234080018133
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of pleura,20346,1892,0.91 [0.76-1.09],0.2829401185315356
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,20021,767,0.75 [0.57-1.00],0.0526524508174443
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other pleural conditions,18507,53,1.10 [0.37-3.30],0.8652306559629621
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20495,405,0.64 [0.43-0.94],0.0231085388098315
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20481,1206,0.86 [0.69-1.08],0.1971592830676015
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural effusion,19404,950,0.93 [0.72-1.21],0.6048312104243677
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural plaque,18688,234,0.52 [0.31-0.86],0.011741777983973
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20157,1587,0.79 [0.64-0.96],0.0169103921804635
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20484,250,1.04 [0.63-1.71],0.8802877819002295
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumothorax,18576,122,1.19 [0.58-2.45],0.6311816264752991
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pollen allergy,20576,206,1.06 [0.61-1.84],0.8434903087926802
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pulmonary oedema,20150,60,1.71 [0.63-4.64],0.295909188411917
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13471,51,0.41 [0.14-1.25],0.1179304191972877
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,20334,821,1.12 [0.85-1.47],0.4304914799480727
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19493,239,1.02 [0.61-1.72],0.9332189570686268
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Viral pneumonia,18800,230,1.26 [0.74-2.12],0.3933639231460933
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",20268,195,1.28 [0.73-2.26],0.3832758359787207
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,9024,102,0.57 [0.26-1.25],0.1580445522881594
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14419,75,0.47 [0.19-1.17],0.1041090532110014
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute appendicitis,20479,124,1.11 [0.54-2.26],0.7816926771796161
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute gastritis,15596,74,1.12 [0.45-2.81],0.8041885213906383
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute pancreatitis,19420,179,0.63 [0.35-1.13],0.1185132135527273
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute peritonitis,20272,78,4.10 [1.69-9.95],0.0017978138164938
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19812,98,0.44 [0.25-0.77],0.0040248460131211
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Barrett oesophagus,15968,446,0.84 [0.58-1.23],0.3777233190525831
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",19347,106,0.95 [0.44-2.04],0.8973030509154909
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",20240,106,0.95 [0.44-2.05],0.905680216616926
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholecystitis,19427,186,0.72 [0.40-1.28],0.2593887923165598
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholelithiasis,19928,687,0.96 [0.71-1.30],0.8009127082302413
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic gastritis,15744,222,0.91 [0.53-1.54],0.7141026295844186
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic pancreatitis,19291,50,0.66 [0.22-1.99],0.4592949163609028
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20410,120,0.86 [0.42-1.75],0.6731791804224219
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Coeliac disease,19176,77,0.92 [0.37-2.29],0.8572786856301295
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Collagenous colitis,19352,42,0.66 [0.20-2.25],0.5103158513208564
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20439,188,0.65 [0.37-1.15],0.1405538535646231
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Constipation,20449,1329,0.85 [0.69-1.06],0.1467638981417162
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn disease,19389,79,0.55 [0.23-1.34],0.1901549001298901
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",20293,58,0.47 [0.17-1.31],0.1477475597123285
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn's disease NAS,19375,65,0.69 [0.26-1.86],0.4668976240376482
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Dental caries,20034,192,1.05 [0.59-1.85],0.8706873692269907
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17457,1674,1.10 [0.91-1.34],0.3274940637938822
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of appendix,20505,150,1.07 [0.56-2.05],0.8361008079262805
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of liver,20471,757,0.56 [0.42-0.74],6.26403298790763e-05
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18865,3343,1.00 [0.87-1.15],0.9844979629047936
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",20273,431,1.00 [0.68-1.46],0.9802265087748788
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20547,353,1.13 [0.74-1.72],0.5748561595757289
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19934,92,0.61 [0.27-1.38],0.2349975581595951
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19819,53,0.83 [0.28-2.47],0.7421204732514427
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of the digestive system,20317,1218,1.03 [0.82-1.29],0.822183499151725
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of tongue,19829,98,1.81 [0.81-4.04],0.1485221483253411
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",20283,1042,0.95 [0.74-1.21],0.6870536135213072
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16986,2642,0.88 [0.75-1.02],0.0964066392747751
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Duodenal ulcer,15743,221,1.20 [0.70-2.05],0.4986670429972072
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20485,170,0.93 [0.51-1.71],0.826580774943845
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20529,37,1.30 [0.35-4.84],0.6950228231353954
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19853,139,0.95 [0.49-1.84],0.8748163752961147
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14495,151,0.61 [0.32-1.15],0.1271244371486489
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Functional dyspepsia,15877,355,0.83 [0.54-1.26],0.3798790047621657
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastric ulcer,15834,312,1.11 [0.71-1.73],0.6572390095825645
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,17373,1851,0.89 [0.74-1.07],0.2099597846567833
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16022,500,1.14 [0.80-1.62],0.4762330988923436
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15756,6880,0.91 [0.83-1.01],0.0684602082619063
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,GI-bleeding,20107,1008,1.02 [0.80-1.31],0.8715187230327921
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19886,44,0.98 [0.30-3.22],0.967638333364179
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15159,1051,1.10 [0.86-1.41],0.444661591895197
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19787,73,1.47 [0.58-3.72],0.4139681213497124
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Hernia,18814,3031,1.03 [0.89-1.19],0.7034162990912689
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impacted teeth,20532,36,1.30 [0.34-4.94],0.7003762665860093
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impaction of intestines,14382,38,4.35 [1.20-15.83],0.0256157056229582
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Inguinal hernia,17188,1405,0.97 [0.78-1.20],0.7571175268592842
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15952,169,0.91 [0.49-1.68],0.7578842375921675
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14423,79,1.19 [0.48-2.92],0.7082491829474645
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal malabsorption,19189,90,1.22 [0.52-2.83],0.6476970347854452
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14587,243,1.71 [1.02-2.86],0.040652303519298
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20555,324,0.51 [0.33-0.79],0.0026392614702205
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19885,575,1.06 [0.76-1.47],0.7487601398883326
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,20069,759,1.06 [0.80-1.42],0.6688561040091797
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15702,180,1.16 [0.64-2.10],0.6200503075369275
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophagitis,16065,543,1.07 [0.76-1.51],0.689556458719366
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20542,99,1.22 [0.55-2.72],0.6260759801297797
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15844,61,1.00 [0.36-2.77],0.9997168047955504
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15589,1245,0.84 [0.67-1.05],0.12154959029879
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,19463,222,1.06 [0.63-1.81],0.818950955229712
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,19344,103,1.23 [0.56-2.69],0.6085602514544209
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestine,15979,1635,0.96 [0.79-1.17],0.7133294307778979
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestines,19024,4680,0.92 [0.82-1.03],0.1519637491874785
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19800,160,1.24 [0.66-2.32],0.5057328393008187
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of liver,20319,605,0.60 [0.43-0.82],0.0014544167220183
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16148,626,0.79 [0.58-1.09],0.1490007714729443
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of pancreas,19359,118,0.85 [0.41-1.76],0.6602018096009845
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20492,298,0.87 [0.55-1.38],0.5591726347357491
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16202,680,1.13 [0.84-1.54],0.4176258037934101
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,20115,1016,1.03 [0.80-1.32],0.823318190619176
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19991,149,0.96 [0.51-1.84],0.9122106289331976
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15705,1361,0.82 [0.66-1.01],0.0642514156868735
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17133,1611,1.00 [0.82-1.22],0.9960037682759888
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19797,83,0.48 [0.20-1.13],0.0928194018063542
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19971,661,1.07 [0.79-1.46],0.6502707387568345
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14641,297,1.07 [0.67-1.70],0.7769041904709062
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20520,45,1.66 [0.51-5.47],0.4014793435830788
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14749,405,1.03 [0.70-1.54],0.8697628362467419
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",19245,146,1.07 [0.56-2.07],0.8332431794829251
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20576,36,0.42 [0.11-1.55],0.1941514256392873
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19848,87,0.86 [0.37-2.03],0.7379737512823846
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Toxic colitis,19349,39,2.84 [0.80-10.06],0.1064048927579246
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15784,262,0.73 [0.45-1.19],0.2115311475430142
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcerative colitis,19438,128,0.81 [0.40-1.63],0.5463471348191486
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19416,106,0.82 [0.38-1.77],0.6063677939698133
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Umbilical hernia,16095,312,0.76 [0.49-1.20],0.2374008548533924
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14481,137,2.88 [1.45-5.73],0.0024730647342013
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ventral hernia,16003,220,1.04 [0.61-1.78],0.875343387861226
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Volvulus,14405,61,0.90 [0.33-2.49],0.8402903844324306
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20535,277,1.87 [1.16-3.01],0.0102655305924343
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,20323,61,1.39 [0.51-3.81],0.523767698449944
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18902,82,3.11 [1.29-7.51],0.0113503247213137
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19953,658,0.71 [0.52-0.96],0.0255317433027607
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19471,176,1.34 [0.74-2.44],0.3363374057119452
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,19200,380,0.96 [0.64-1.44],0.8451056057122922
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,20334,234,0.87 [0.52-1.46],0.6029447158959937
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20505,405,0.80 [0.54-1.19],0.2672877495042987
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,20139,39,0.65 [0.18-2.29],0.4977727019966598
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19294,2710,0.96 [0.82-1.11],0.5661990971523035
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,20191,342,0.58 [0.38-0.89],0.0131500155234495
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,20090,241,0.67 [0.40-1.11],0.1232613571162235
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,20185,890,0.82 [0.63-1.07],0.1443279396408806
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20580,26,2.61 [0.55-12.34],0.2259824349563925
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18842,22,0.63 [0.12-3.40],0.5926473194942998
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19902,53,0.92 [0.32-2.69],0.8847496284773285
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,20330,230,0.88 [0.52-1.48],0.6198116101156887
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,19233,413,1.46 [0.99-2.17],0.0569672763596123
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18887,67,2.75 [1.05-7.26],0.0404321353505075
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20533,71,0.56 [0.22-1.43],0.2296858006038072
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19467,172,0.72 [0.39-1.31],0.2840292102089999
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,20444,182,0.61 [0.34-1.09],0.0968514132020916
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,20159,59,0.90 [0.32-2.53],0.848179020917608
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18874,54,2.38 [0.80-7.04],0.1183081232386669
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20196,1376,1.24 [1.00-1.53],0.0508934599443754
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",19269,449,1.30 [0.89-1.89],0.1747244055388426
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18890,70,2.81 [1.09-7.24],0.0329951788340562
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20513,251,0.97 [0.59-1.60],0.901857969601551
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,20146,46,0.82 [0.26-2.61],0.739032657572996
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20482,220,0.77 [0.45-1.31],0.3357317256120754
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20550,292,1.89 [1.19-3.01],0.0071071998353971
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18898,78,3.18 [1.29-7.84],0.0117830251693721
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,19049,229,0.83 [0.49-1.41],0.4913637544622619
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20544,286,1.84 [1.15-2.94],0.0109369224832268
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",19036,216,1.59 [0.93-2.71],0.0918967400089354
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20567,105,0.52 [0.24-1.12],0.0931504503262426
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17755,71,2.03 [0.79-5.23],0.1403517946360369
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18771,4096,0.98 [0.87-1.11],0.7812150466218755
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17564,2889,0.97 [0.84-1.13],0.7158128488245539
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17750,66,0.93 [0.35-2.50],0.8926187441516565
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18101,123,1.72 [0.84-3.52],0.1383002674060893
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18100,122,1.25 [0.61-2.57],0.5422408012551481
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,20412,57,2.90 [1.02-8.20],0.045283206124606
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18044,66,0.35 [0.13-0.93],0.0350372137314971
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15420,745,0.90 [0.67-1.20],0.4626702284810348
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20484,128,1.25 [0.62-2.51],0.53422645098131
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18206,228,1.05 [0.62-1.77],0.8621926199463469
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17516,5368,0.96 [0.86-1.07],0.4857805584830599
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19693,85,0.50 [0.21-1.17],0.111541828822333
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17827,143,1.34 [0.69-2.60],0.3890361218583361
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,18075,391,0.95 [0.63-1.42],0.7864077276937109
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19870,1892,0.96 [0.80-1.15],0.6290639947413628
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,18005,321,0.99 [0.63-1.54],0.9510548014233086
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17732,48,0.63 [0.20-2.01],0.4395402309689941
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17770,86,0.68 [0.29-1.61],0.3815157652310347
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,20307,27,0.30 [0.07-1.34],0.1144046606631376
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15921,1246,0.98 [0.78-1.22],0.8303424451039993
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15499,824,0.81 [0.61-1.06],0.1295842758804372
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20467,811,0.79 [0.60-1.04],0.09606026559914
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14713,38,1.25 [0.34-4.60],0.7399752080087794
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14744,69,2.52 [0.96-6.67],0.0616218690088911
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17911,227,0.79 [0.46-1.34],0.3753425935654715
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,15215,540,1.19 [0.84-1.68],0.3220580194608501
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18015,37,0.62 [0.17-2.29],0.475018592971392
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18421,443,1.25 [0.86-1.83],0.24340121652062
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18201,223,0.96 [0.57-1.65],0.8944832140383526
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,15179,504,1.14 [0.80-1.64],0.4591596100831507
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17740,56,1.97 [0.68-5.71],0.209530510686393
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17726,42,2.83 [0.83-9.68],0.0971236658325511
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19687,79,1.29 [0.54-3.11],0.5702005697947468
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20340,732,0.88 [0.66-1.18],0.3925826705621813
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19945,337,0.54 [0.35-0.83],0.0045193755114763
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20524,259,0.96 [0.58-1.56],0.8540178428331744
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16290,1615,1.02 [0.84-1.24],0.8618558657485096
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14721,46,1.24 [0.37-4.08],0.7285538277387752
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17751,67,0.81 [0.30-2.15],0.6690636347224397
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14725,50,0.64 [0.21-1.97],0.4387483477639021
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14713,38,1.57 [0.42-5.77],0.5007414564973406
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19765,157,1.98 [1.05-3.74],0.034472391901754
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19748,140,0.89 [0.45-1.74],0.7321528803413715
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20561,73,0.44 [0.18-1.11],0.0809501582655955
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19269,1291,1.16 [0.93-1.45],0.1776779382132928
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17741,57,2.02 [0.70-5.86],0.1942281365615435
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14711,36,0.62 [0.16-2.39],0.4899248004023745
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18509,531,1.03 [0.73-1.45],0.8679487129210578
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16144,1469,1.18 [0.96-1.45],0.122035927956539
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,20326,46,0.91 [0.29-2.93],0.8798054055747637
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20576,56,1.52 [0.53-4.37],0.4339614510962415
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17756,72,0.85 [0.34-2.17],0.7376628959683889
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18524,840,1.36 [1.03-1.79],0.0282101982730855
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17763,79,2.00 [0.81-4.91],0.1316154351768156
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15721,1046,1.07 [0.84-1.37],0.5915775914799433
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19678,70,1.86 [0.71-4.83],0.2039075337837053
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17722,38,1.37 [0.37-5.13],0.6368389358741771
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18074,96,0.85 [0.38-1.90],0.6851382110295905
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18112,428,1.37 [0.93-2.01],0.1105096405678447
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,20447,167,0.54 [0.29-0.99],0.0464522233402137
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18391,413,1.04 [0.70-1.54],0.8430907309213536
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20532,255,0.93 [0.57-1.52],0.759930865304767
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20577,34,0.33 [0.09-1.25],0.1026515045387044
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17817,133,1.34 [0.67-2.69],0.4030220966037209
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16907,493,1.25 [0.87-1.78],0.2287961875512755
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,18089,405,1.11 [0.75-1.64],0.6111488440689188
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17974,290,1.00 [0.63-1.60],0.9867554189551117
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14701,26,0.72 [0.33-1.60],0.4207838025964341
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16624,1949,0.92 [0.77-1.10],0.3804663769083415
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15054,379,1.05 [0.70-1.58],0.804906115304894
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,20419,139,0.57 [0.29-1.11],0.0968335813324069
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20525,37,0.98 [0.27-3.59],0.9709485999561656
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18883,37,1.78 [0.50-6.31],0.373515476579624
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14733,58,1.52 [0.53-4.32],0.4320682118994809
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18055,77,1.05 [0.42-2.60],0.9218592080706308
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14941,266,0.96 [0.59-1.57],0.8767870823617754
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17935,251,0.98 [0.59-1.63],0.9517325312390954
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18164,186,0.97 [0.54-1.73],0.9111656906121453
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18052,74,1.23 [0.49-3.08],0.6656454742726567
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16362,26,0.32 [0.07-1.49],0.1483534149819373
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20578,35,0.38 [0.10-1.41],0.1472461037827232
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,18140,456,0.99 [0.68-1.43],0.9477666336412764
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],20297,17,0.50 [0.08-3.35],0.4780969786893211
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19655,1971,1.07 [0.89-1.28],0.4833073006197462
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17777,93,0.51 [0.22-1.15],0.1029783737425879
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18402,424,1.05 [0.71-1.54],0.8045164390984495
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19665,171,0.69 [0.38-1.26],0.2257871258075112
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18096,118,1.25 [0.60-2.60],0.5543580020454077
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19094,1116,0.94 [0.74-1.19],0.5813735734020846
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18666,688,1.06 [0.78-1.43],0.7278487274646437
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17718,34,1.78 [0.45-7.06],0.4134502534814117
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,20318,38,0.38 [0.11-1.37],0.1403116058131328
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17795,111,0.68 [0.32-1.44],0.3152377921129808
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17703,19,2.35 [0.38-14.52],0.3567734977399387
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14727,52,6.37 [2.14-18.92],0.0008663778342778
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19831,1554,1.62 [1.32-1.98],3.387174368103763e-06
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,20187,344,0.78 [0.51-1.20],0.2554290815109468
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19967,124,1.32 [0.65-2.69],0.4412610121235555
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19435,1158,3.11 [2.46-3.93],2.1257501456838648e-21
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,20384,51,15.04 [5.25-43.11],4.537703074425729e-07
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,20377,301,1.34 [0.85-2.11],0.211437734967712
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cystitis,18175,176,0.91 [0.50-1.64],0.7450211339640735
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Dialysis,18347,70,3.65 [2.21-6.03],4.299760896210886e-07
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19503,2854,1.02 [0.88-1.18],0.8139705558167208
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18611,4781,1.13 [1.01-1.27],0.0369931978330863
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,20409,76,17.42 [7.35-41.27],8.56757546858546e-11
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hydrocele,16825,176,1.02 [0.56-1.86],0.9416574094149904
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,18349,301,1.83 [1.15-2.92],0.011378139419245
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18892,2243,1.00 [0.85-1.19],0.9713557075968442
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16847,198,1.22 [0.69-2.16],0.4849230373321632
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18061,62,1.61 [0.59-4.37],0.3545983733163961
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16750,101,0.75 [0.34-1.64],0.4694538718572117
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20583,53,0.97 [0.33-2.84],0.9485080225630952
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20581,45,0.66 [0.20-2.13],0.4852837334240059
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19884,1885,1.22 [1.02-1.46],0.0324263554254183
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18824,825,0.99 [0.75-1.30],0.9234541039585624
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20530,454,1.98 [1.37-2.87],0.0003078519557179
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16915,266,1.39 [0.85-2.27],0.1864646262038987
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16892,243,0.85 [0.51-1.42],0.5366992035990765
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16847,198,1.04 [0.59-1.83],0.8863637492102497
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20579,42,1.76 [0.52-5.94],0.3598807891382188
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19256,1257,1.41 [1.13-1.76],0.0023363237897015
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18385,337,1.96 [1.26-3.04],0.0028597152127683
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,20225,149,3.58 [1.87-6.83],0.0001105555783078
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,20387,54,3.43 [1.18-9.98],0.0238652070543071
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16880,231,1.34 [0.79-2.27],0.2714783339715979
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20370,2322,1.74 [1.48-2.06],5.3971845157810365e-11
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18103,55,1.79 [0.60-5.36],0.2947115931115877
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18394,117,2.15 [1.02-4.53],0.0439720348713906
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19906,63,0.42 [0.16-1.13],0.0856801032566924
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18253,254,1.05 [0.64-1.73],0.8429779078039589
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urolithiasis,20291,448,0.81 [0.56-1.18],0.2805216816091166
